Type One Diabetes Completed Phase 4 Trials for Insulin lispro (DB00046)
Also known as: Diabetes Mellitus, Juvenile-Onset / T1DM - Type 1 Diabetes Mellitus / Diabetes Type I / Type I Diabetes / Type1 Diabetes / Diabetes Type One / Diabete Type 1 / Type One Diabetes Mellitus / Diabetics Mellitus Type 1 / Type 1 Diabetes / Type 1 Diabetes Mellitus (T1DM) / Insulin-Dependent Diabetes Mellitus 1 / Type1diabetes / Diabetes Mellitus Type I / Type1 Diabetes Mellitus / Type 1 Diabetes (T1D) / Diabetes Mellitus Type 1 / Juvenile Onset Diabetes Mellitus / Diabetes Type 1 / Type 1 Insulin-Dependent Diabetes Mellitus / Type I Diabetes Mellitus / Diabetes Mellitus, Sudden-Onset / Type-1 Diabetes Mellitus / Insulin Dependent Diabetes Mellitus 1 / Type 1 Diabetes Mellitus / Juvenile-Onset Diabetes / Diabetes Mellitus, Insulin-Dependent, 1 / Diabetes mellitus type 1 (disorder) / Diabetes mellitus: [juvenile] or [insulin dependent] / Juvenile diabetes / Insulin dependent diabetic / IDDM / Diabetes mellitus insulin-dependent / Insulin-dependent diabetes mellitus / Diabetes mellitus juvenile onset / Immune-mediated diabetes / Insulin dependent diabetes mellitus / Insulin dependent diabetes mel / IDDM - Insulin-dependent diabetes mellitus / Diabetes mellitus - juvenile / Ketosis-prone diabetes mellitus (disorder) / Ketosis-prone diabetes mellitus
| Indication | Status | Phase |
|---|---|---|
| DBCOND0076728 (Type One Diabetes) | Completed | 4 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02276859 | Normal Versus Dual Wave Insulin Bolus for High-protein Food | Treatment | |
| NCT01269047 | Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia | Treatment | |
| NCT01269034 | New Onset Type 1 Diabetes: Role of Exenatide | Treatment | |
| NCT04019821 | Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal | Treatment | |
| NCT01526733 | Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase | Treatment | |
| NCT03328845 | Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study) | Treatment | |
| NCT03662334 | A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20) | Treatment | |
| NCT00607087 | Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus | Treatment | |
| NCT00461331 | Comparison of Insulins Aspart and Lispro in Insulin Pumps | Treatment | |
| NCT00985712 | A Study on the Effect of 2 Pen Devices on HbA1c | Treatment | |
| NCT00420095 | A Study for Patients With Diabetes Mellitus (IOPA) | Treatment | |
| NCT01848990 | CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) | Treatment | |
| NCT04124302 | The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal. | Treatment |